European shares rise on COVID-19 drug hopes, upbeat outlook from corporates

(Reuters) - European stocks rose on Wednesday, as positive developments regarding a potential COVID-19 treatment bolstered a rally in banks and oil stocks and shares in sensor specialist AMS jumped on upbeat earnings. Global sentiment got a boost after U.S. drugmaker Gilead Sciences said its experimental antiviral drug remdesivir helped improve symptoms for COVID-19 patients who were given the drug early.[.N]"Risk appetite is roaring back on news that... remdesivir met the primary endpoint,"..